Schonfeld Strategic Advisors LLC Sells 4,442 Shares of Danaher Co. (NYSE:DHR)

Schonfeld Strategic Advisors LLC lessened its stake in shares of Danaher Co. (NYSE:DHR - Free Report) by 9.6% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 41,697 shares of the conglomerate's stock after selling 4,442 shares during the quarter. Schonfeld Strategic Advisors LLC's holdings in Danaher were worth $9,572,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the company. 11 Capital Partners LP boosted its position in Danaher by 40.2% during the 4th quarter. 11 Capital Partners LP now owns 59,819 shares of the conglomerate's stock worth $13,731,000 after buying an additional 17,140 shares during the period. AQR Capital Management LLC increased its holdings in Danaher by 4.3% in the fourth quarter. AQR Capital Management LLC now owns 376,906 shares of the conglomerate's stock valued at $86,519,000 after purchasing an additional 15,537 shares during the period. Perbak Capital Partners LLP bought a new position in Danaher during the 4th quarter worth $1,127,000. Hhlr Advisors LTD. raised its position in Danaher by 43.7% during the 4th quarter. Hhlr Advisors LTD. now owns 13,079 shares of the conglomerate's stock worth $3,002,000 after purchasing an additional 3,975 shares during the last quarter. Finally, Caden Capital Partners LP grew its position in shares of Danaher by 79.8% in the 4th quarter. Caden Capital Partners LP now owns 209,149 shares of the conglomerate's stock valued at $48,010,000 after buying an additional 92,795 shares during the last quarter. 79.05% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on DHR shares. Citigroup reaffirmed a "buy" rating on shares of Danaher in a research note on Monday, April 7th. Jefferies Financial Group reduced their price objective on shares of Danaher from $260.00 to $230.00 and set a "buy" rating for the company in a research report on Tuesday, April 22nd. Raymond James reaffirmed a "market perform" rating on shares of Danaher in a research note on Monday, February 3rd. Barclays boosted their target price on shares of Danaher from $205.00 to $215.00 and gave the stock an "overweight" rating in a research report on Tuesday, April 22nd. Finally, Royal Bank of Canada restated an "outperform" rating and issued a $250.00 price objective on shares of Danaher in a research note on Wednesday, April 23rd. Five research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $264.40.

Danaher Trading Down 1.4 %

Shares of Danaher stock traded down $2.74 during trading on Tuesday, reaching $194.66. 1,302,312 shares of the stock were exchanged, compared to its average volume of 3,359,374. The firm has a market cap of $139.31 billion, a price-to-earnings ratio of 36.88, a price-to-earnings-growth ratio of 2.66 and a beta of 0.80. The stock's fifty day moving average is $199.54 and its 200 day moving average is $220.89. Danaher Co. has a 1 year low of $171.00 and a 1 year high of $281.70. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR - Get Free Report) last released its earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.62 by $0.26. The firm had revenue of $5.74 billion during the quarter, compared to analyst estimates of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. As a group, equities research analysts expect that Danaher Co. will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 25th. Shareholders of record on Friday, March 28th were paid a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a yield of 0.66%. This is an increase from Danaher's previous quarterly dividend of $0.27. The ex-dividend date of this dividend was Friday, March 28th. Danaher's dividend payout ratio (DPR) is currently 24.85%.

Insider Activity

In related news, EVP Christopher Paul Riley sold 15,805 shares of the stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president now directly owns 15,179 shares of the company's stock, valued at approximately $3,005,442. This represents a 51.01 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 11.10% of the stock is owned by corporate insiders.

Danaher Company Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.